Autophagy in Melanoma: Molecular Mechanisms and Therapeutic Perspectives

Dominika Stencel1, Dorota Wrześniok1

  • 1Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.

Insights

Melanoma, a dangerous skin cancer, involves autophagy, a cellular process. Research explores using autophagy modulators to enhance melanoma treatment effectiveness.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Melanoma is a significant public health concern due to its high metastatic potential and treatment resistance.
  • Autophagy is a cellular degradation process crucial for maintaining homeostasis and cell survival.
  • Autophagy exists in three main forms: macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA).

Purpose of the Study:

  • To explore the multifaceted role of autophagy in melanoma development and progression.
  • To investigate how autophagy influences cancer characteristics such as inflammation, apoptosis crosstalk, and therapeutic resistance.
  • To evaluate the potential of modulating autophagy as a therapeutic strategy for melanoma.

Main Methods:

  • Literature review of current research on autophagy and melanoma.
  • Analysis of studies investigating the dual role of autophagy (tumor-promoting vs. tumor-suppressive) in different cancer contexts.
  • Examination of preclinical and clinical data on autophagy inhibitors and inducers in melanoma models.

Main Results:

  • Autophagy's role in oncogenesis is complex and context-dependent, varying with cancer type and stage.
  • Autophagy can act as either a tumor promoter or a tumor suppressor in melanoma.
  • Factors like inflammation and crosstalk with apoptosis significantly influence autophagy's function in cancer.

Conclusions:

  • Targeting autophagy presents a promising avenue for improving melanoma treatment efficacy.
  • Both autophagy inhibitors and inducers are being explored as potential therapeutic agents.
  • Further research is needed to fully elucidate and harness the therapeutic potential of autophagy modulation in melanoma.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...